Spots Global Cancer Trial Database for neoplasms, prostate
Every month we try and update this database with for neoplasms, prostate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) | NCT04249947 | Prostatic Neopl... Neoplasms by Hi... Neoplasms, Pros... Prostate Cancer Metastatic Cast... Neoplasms Prostatic Neopl... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Prostatic Disea... Salivary Gland ... Salivary Gland ... Adenoid Cystic ... Salivary Duct C... Mucoepidermoid ... Acinic Cell Tum... | P-PSMA-101 CAR-... Rimiducid | 18 Years - | Poseida Therapeutics, Inc. | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy | NCT02652000 | Neoplasms, Pros... | No intervention... | 48 Years - 80 Years | Kantonsspital Graubuenden | |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) | NCT01371513 | Neoplasms, Pros... Prostate Cancer Benign Prostati... | continuous scre... | 40 Years - | GlaxoSmithKline | |
| "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk | NCT00056407 | Neoplasms, Pros... | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Positioning and Tracking the Prostate During External Beam Radiation | NCT00123838 | Prostate Cancer | Calypso® 4D Loc... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy | NCT00470834 | Neoplasms, Pros... | dutasteride placebo bicalutamide | 40 Years - 90 Years | GlaxoSmithKline | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| ARI103094-Follow-Up Study for REDUCE Study Subjects | NCT00883909 | Neoplasms, Pros... | dutasteride | 50 Years - | GlaxoSmithKline | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) | NCT01371513 | Neoplasms, Pros... Prostate Cancer Benign Prostati... | continuous scre... | 40 Years - | GlaxoSmithKline | |
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer | NCT00417274 | Prostatic Cance... | Quinacrine | 18 Years - | Cleveland BioLabs | |
| Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA | NCT00148928 | Neoplasms, Pros... | P501-AS15 vacci... | 18 Years - 75 Years | GlaxoSmithKline | |
| Positioning and Tracking the Prostate During External Beam Radiation | NCT00123838 | Prostate Cancer | Calypso® 4D Loc... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men | NCT00363311 | Neoplasms, Pros... | Dutasteride Matching placeb... | 50 Years - 80 Years | GlaxoSmithKline | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
